Pancreatic cancer: Advances and challenges

CJ Halbrook, CA Lyssiotis, MP di Magliano, A Maitra - Cell, 2023 - cell.com
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest cancers. Significant
efforts have largely defined major genetic factors driving PDAC pathogenesis and …

Epigenetic regulation of hybrid epithelial-mesenchymal cell states in cancer

RA Sample, MF Nogueira, RD Mitra, SV Puram - Oncogene, 2023 - nature.com
Epithelial-to-mesenchymal transition (EMT) is a process by which cells lose their epithelial
characteristics and gain mesenchymal phenotypes. In cancer, EMT is thought to drive tumor …

[HTML][HTML] Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer

FJ de Miguel, C Gentile, WW Feng, SJ Silva, A Sankar… - Cancer Cell, 2023 - cell.com
Acquired resistance to tyrosine kinase inhibitors (TKI), such as osimertinib used to treat
EGFR-mutant lung adenocarcinomas, limits long-term efficacy and is frequently caused by …

ARID1A mutations in cancer development: mechanism and therapy

X Zhang, Y Zhang, J Zhao, Y Wu, N Zhang… - …, 2023 - academic.oup.com
Abstract AT-Rich Interaction Domain 1A (ARID1A) is an important SWItch/Sucrose Non-
Fermentation (SWI/SNF) chromatin remodeling complex subunit, and its coding gene has a …

Epithelial to mesenchymal transition: key regulator of pancreatic ductal adenocarcinoma progression and chemoresistance

K Palamaris, E Felekouras, S Sakellariou - Cancers, 2021 - mdpi.com
Simple Summary Pancreatic ductal adenocarcinoma's (PDAC) dismal prognosis is
associated with its aggressive biological behavior and resistance to chemotherapy …

Chromatin remodeling induced by ARID1A loss in lung cancer promotes glycolysis and confers JQ1 vulnerability

X Liu, Z Li, Z Wang, F Liu, L Zhang, J Ke, X Xu, Y Zhang… - Cancer research, 2022 - AACR
ARID1A is a key mammalian SWI/SNF complex subunit that is mutated in 5% to 11% of lung
cancers. Although recent studies have elucidated the mechanism underlying dysregulation …

The effects of ARID1A mutation in gastric cancer and its significance for treatment

S Lu, R Duan, L Cong, Y Song - Cancer Cell International, 2023 - Springer
Gastric cancer (GC) has emerged as a significant issue in public health all worldwide as a
result of its high mortality rate and dismal prognosis. AT-rich interactive domain 1 A …

[HTML][HTML] Pancreatic adenocarcinomas without KRAS, TP53, CDKN2A and SMAD4 mutations and CDKN2A/CDKN2B copy number alterations: a review of the genomic …

IA Voutsadakis, A Digklia - Chinese Clinical Oncology, 2023 - cco.amegroups.org
Background: Pancreatic adenocarcinoma is one of the cancers with the worst prognosis.
The current treatment paradigm based on combination chemotherapy has improved survival …

The Prognostic Value of AT‐Rich Interaction Domain (ARID) Family Members in Patients with Hepatocellular Carcinoma

S Li, Z Wu, Q Li, Q Liang, H Zhou, Y Shi… - Evidence‐Based …, 2022 - Wiley Online Library
Objective. Hepatocellular carcinoma (HCC) is one of the most lethal malignancies with a
poor prognosis. The AT‐rich interaction domain (ARID) family plays an essential regulatory …

The Role of the AT-Rich Interaction Domain 1A Gene (ARID1A) in Human Carcinogenesis

JJ Li, CS Lee - Genes, 2023 - mdpi.com
The switch/sucrose non-fermentable (SWI/SNF)(SWI/SNF) complex uses energy from ATP
hydrolysis to mobilise nucleosomes on chromatin. Components of SWI/SNF are mutated in …